Please login to the form below

Not currently logged in
Email:
Password:

IWS

This page shows the latest IWS news and features for those working in and with pharma, biotech and healthcare.

Blow for Entresto in latest heart failure trial

Blow for Entresto in latest heart failure trial

Another contender is Cyclerion Therapeutics's praliciguat (IW-1973), an oral soluble guanylate cyclase (sGC) stimulator currently in phase 2  trials.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....